Lap band surgery effective for morbidly obese adolescents, improves glucose metabolism

In FDA-approved trial, adolescents had 45 percent weight loss 2 years after surgery

Washington, DC-A surgeon now at Children's National Medical Center and his colleagues from New York University have found laparoscopic adjustable gastric banding (Lap band) to improve the health of morbidly obese adolescents.

The study, published in the Journal of the American College of Surgeons, involved nearly 50 girls and boys ages 14-17. The participants showed significant decreases in total and android fat mass 2 years after surgery. Android fat has been linked to the development of obesity-related illnesses, such as diabetes, heart disease, and insulin resistance.

"This study is the first to demonstrate the improvements in overall health and distribution of weight loss after Lap band surgery in adolescents," said Evan Nadler, MD, the lead author and pediatric surgeon at Children's National. "While weight-loss surgery should always be a last resort for adults and adolescents, these findings show us that surgery in adolescents reduces the risk of significant health complications."

The study found that Lap band surgery improved glucose metabolism, reducing the adolescents' risk of developing insulin resistance. Additionally, bone mineral density was not impacted by the surgery, suggesting that bone growth is not affected.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New glucose-sensitive insulin NNC2215 could transform diabetes care by lowering hypoglycemia risk